NCT02728258 · Interventional trial
Copanlisib in Treating Patients With Persistent or Recurrent Endometrial Cancer
Overall registry status Completed
Phase 2
Conditions Endometrial Endometrioid Adenocarcinoma, Endometrial Mixed Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma, Endometrial Undifferentiated Carcinoma, Metastatic Endometrioid Adenocarcinoma, Recurrent Uterine Corpus Cancer
Delaware Valley sites
- University of Pennsylvania/Abramson Cancer Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory